Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation

Sara Piccinelli, Antonella Mancusi, PhD, Eni Hoxha, Loredana Ruggeri, MD, Franca Falzetti, MD, Alessandra Carotti, MD, Adelmo Terenzi, MD, Samanta Bonato, MD, Matteo Paradiso, MD, Tiziana Zei, Roberta Iacucci Ostini, Barbara Bigerna, Brunangelo Falini, MD PhD, Mauro Di Ianni, MD PhD, Massimo Fabrizio Martelli, MD, Andrea Velardi, MD, Antonio Pierini, MD PhD

Blood (2019) 134 (Supplement_1): 1917.

https://doi.org/10.1182/blood-2019-125715

Published: 2019

Journal Articles

Adoptive Immunotherapy with Regulatory and Conventional T Cells in Haploidentical Transplantation Primes Dendritic Cells to Promote T Cell Alloreactivity in the Bone Marrow and Tolerance in the Periphery

Mauro Di Ianni, MD PhD, Raffaella Giancola, Stefano Baldoni, Francesca Ulbar, Beatrice Del Papa, Stella Santarone, Annalisa Natale, Paola Olioso, Paolo Di Bartolomeo, Tiziana Bonfini, Patrizia Accorsi, Paolo Sportoletti, Alessandra Carotti, MD, Antonio Pierini, MD PhD, Loredana Ruggeri, MD, Franca Falzetti, MD, Massimo Fabrizio Martelli, MD, Andrea Velardi, MD

Blood (2019) 134 (Supplement_1): 3224.

https://doi.org/10.1182/blood-2019-126061

Published: 2019

Journal Articles

Activation of Regulatory T Cells with IL-2 and TNF-α to Promote Homing to the Gut and to Improve Acute GvHD Prevention

Antonella Mancusi, PhD, Samanta Bonato, MD, Rachele Del Sordo, MD, Sara Piccinelli, Eni Hoxha, Tiziana Zei, Roberta Iacucci Ostini, Franca Falzetti, MD, Alessandra Carotti, MD, Loredana Ruggeri, MD, Michele Giansanti, MD, Robert S. Negrin, MD, Massimo Fabrizio Martelli, MD, Andrea Velardi, MD, Antonio Pierini, MD PhD

Blood (2019) 134 (Supplement_1): 4447.

https://doi.org/10.1182/blood-2019-123202

Published: 2019

Journal Articles

Low-Toxicity/High-Efficacy HLA Haploidentical Transplantation for Elderly/Unfit Patients with Acute Leukemia

Andrea Velardi, MD, Alessandra Carotti, MD, Franca Falzetti, MD, Adelmo Terenzi, MD, Loredana Ruggeri, MD PhD, Antonio Pierini, MD PhD, Sara Piccinelli, MD, Sara Tricarico, MD, Amico Lucia, MD, Genni Casarola, MD, Valentina Lancillotta, MD, Simonetta Saldi, MD, Mauro Di Ianni, MD PhD, Cynthia Aristei, MD PhD, Massimo Fabrizio Martelli, MD PhD

Blood (2017) 130 (Supplement 1): 4601.

https://doi.org/10.1182/blood.V130.Suppl_1.4601.4601

Published: 2017

Journal Articles

Allogeneic Genetically Modified T Cells (HSV-TK) As Adjunctive Treatment in Haploidentical Hematopoietic Stem-Cell Transplantation (haplo-HSCT) of Adult Patients with High-Risk Hematological Malignancies: A Pair-Matched Analysis from the Acute Leukemia Working Party of EBMT

Mohamad Mohty, MD PhD, Myriam Labopin, MD, Andrea Velardi, MD, Maria Teresa van Lint, MD, Donald Bunjes, Benedetto Bruno, MD PhD, Stella Santarone, MD, Johanna Tischer, Yener Koc, MD, Depei Wu, MDPhD, Zafer Gulbas, MD, Annalisa Ruggeri, MD, Florent Malard, MD PhD, Simona Piemontese, MD, Maria Teresa Lupo Stanghellini, MD, Chiara Bonini, MD, Claudio Bordignon, MD, Fabio Ciceri, MD, Arnon Nagler

Blood (2016) 128 (22): 672.

https://doi.org/10.1182/blood.V128.22.672.672

Published: 2016

Journal Articles

Alternative Donors (Umbilical Cord Blood and Haploidentical Donors) for Allogeneic Stem Cell Transplantation in Relapsed / Refractory Hodgkin Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party and the Spanish Group of Stem Cell Transplantation (GETH)

Blood (2015) 126 (23): 4399.

https://doi.org/10.1182/blood.V126.23.4399.4399

Published: 2015

Journal Articles

Myeloablative Versus Reduced Intensity Allogeneic Stem Cell Transplantation in Relapsed Hodgkin’s Lymphoma in Recent Years. a Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Sonja G Genadieva Stavrik, MDPhD, Ariane Boumendil, Kirsty Thomson, Javier Briones, MD, Paolo Corradini, MD, Andrea Bacigalupo, MD, Gerard Socie, Guiseppe Bandini, Herve Finel, Andrea Velardi, MD, Michael Potter, PhD, Bruno Benedetto, Luca Castagna, MD, Charles Craddock, MDPhD, Nigel Russell, Peter Dreger, MD, Sureda Anna

Blood (2014) 124 (21): 2562.

https://doi.org/10.1182/blood.V124.21.2562.2562

Published: 2014

Journal Articles

Haploidentical Mismatched Allogeneic Versus Autologous Hematopoietic STEM CELL Transplantation in Adult Patients with ACUTE Myeloid Leukemia (AML) in First Complete Remission (CR1): A Pair-Matched Analysis From the Acute Leukemia Working Party of EBMT.

Norbert C. Gorin, MD, PhD, Myriam Labopin, Fabio Ciceri, MD, Andrea Velardi, MD, PhD, Stella Santarone, MD, William Arcese, MD, Mohamad Mohty, MD PhD

Blood (2012) 120 (21): 3093.

https://doi.org/10.1182/blood.V120.21.3093.3093

Published: 2012

Journal Articles

Reduction in Incidence of Severe Infections by Transplantation of High Doses of Haploidentical T Cells Selectively Depleted of Alloreactive Units

Denis-Claude Roy, MD, Mireille Guerin, MSc, Radia Sidi Boumedine, MSc, Silvy Lachance, MD, Sandra Cohen, MD, Guy Sauvageau, MD, PhD, Thomas Kiss, MD, Lambert Busque, MD, Jean Morin, Marie-Claude Guertin, PhD, Andrea Velardi, MD, PhD, Katayoun Rezvani, MD, PhD, Stephan Mielke, MD, R. Maarten Egeler, MD, PhD, A. John Barrett, MD, Claude Perreault, MD, Jean Roy, MD

Blood (2011) 118 (21): 3020.

https://doi.org/10.1182/blood.V118.21.3020.3020

Published: 2011

Journal Articles

Permissive HLA-DPB1 Mismatching Compared to a Non-Permissive Mismatching Significantly Improves Overall Survival Following Allogeneic Transplantation In Patients with Both 10/10 and 9/10 Matched Unrelated Donors

Bronwen E. Shaw, PhD, MRCP, FRCPath, Katharina Fleischhauer, PhD, Mari Malkki, Theodore Gooley, PhD, Elisabetta Zino, PhD, Stephen Spellman, PhD, Yasuo Morishima, MD, Andrea Velardi, MD, PhD, Peter Bardy, MD, Jean-denis Bignon, J. Alejandro Madrigal, MD, PhD, Effie W. Petersdorf, MD

Blood (2010) 116 (21): 227.

https://doi.org/10.1182/blood.V116.21.227.227

Published: 2010

Journal Articles

Adoptive Therapy with T-Cell Precursors for Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation.

Emanuela Burchielli, Antonella Tosti, Loredana Ruggeri, Katia Perruccio, Claudia De Angelis, Andrea Velardi, MD

Blood (2009) 114 (22): 3525.

https://doi.org/10.1182/blood.V114.22.3525.3525

Published: 2009

Journal Articles

Adoptive Immunotherapy after Haploidentical Stem Cell Transplantation with T Cells Allodepleted by Photodynamic Purging

Katia Perruccio, MD, PhD, Fabiana Topini, MSc, Antonella Tosti, Tech, Alessandra Carotti, MD, Teresa Aloisi, MD, Franco Aversa, MD, Massimo F Martelli, MD, Andrea Velardi, MD

Blood (2008) 112 (11): 1157.

https://doi.org/10.1182/blood.V112.11.1157.1157

Published: 2008

Journal Articles

Phase I-II Trial of Adoptive Immunotherapy with Haploidentical KIR Ligand-Mismatched Natural Killer Cells in High Risk Acute Myeloblastic Leukemia Patients.

Antonio Curti, MD, Loredana Ruggeri, BS, Alessandra D’Addio, MD, Elena Urbani, BS, Andrea Bontadini, MD, Fiorenza Fruet, BS, Valeria Giudice, MD, Elisa Dan, BS, Maria Rosa Motta, BS, Simona Rizzi, BS, Stefania Paolini, MD, Gabriele Gugliotta, MD, Roberto Conte, MD, Giovanni Martinelli, MD, Andrea Velardi, MD, Michele Baccarani, MD, Roberto M. Lemoli, MD

Blood (2007) 110 (11): 2857.

https://doi.org/10.1182/blood.V110.11.2857.2857

Published: 2007

Journal Articles

Anti-KIR (1-7F9): A Fully Human Monoclonal Antibody (mAb) That Blocks KIR2DL1, −2 and −3, Promoting Natural Killer (NK) Cell-Mediated Lysis of Tumor Cells In Vitro and In Vivo.

Nicolai Wagtmann, PhD, Pascale Andre, PhD, Stefan Zahn, PhD, Pieter Spee, PhD, Nicolas Anfossi, PhD, Laurent Gauthier, PhD, Bradley W. Blaser, PhD, Michael A. Caligiuri, MD, Marusca Capanni, Loredana Ruggeri, PhD, Andrea Velardi, MD, Francois Romagne, PhD

Blood (2007) 110 (11): 582.

https://doi.org/10.1182/blood.V110.11.582.582

Published: 2007

Journal Articles

Alloreactive Natural Killer Cells Rebuild Adaptive Immunity to Infections after Haploidentical Hematopoietic Transplantation.

Loredana Ruggeri, MD, PhD, Emanuela Burchielli, MD, PhD, Katia Perruccio, MD, PhD, Marusca Capanni, Martin Stern, MD, PhD, Kathrin Hafen, Franco Aversa, MD, Massimo F. Martelli, MD, PhD, Luigina Romani, MD, PhD, George Hollander, MD, PhD, Andrea Velardi, MD, PhD

Blood (2006) 108 (11): 3210.

https://doi.org/10.1182/blood.V108.11.3210.3210

Published: 2006

Journal Articles

Donor Natural Killer Cell Allorecognition of Missing Self in Haploidentical Hematopoietic Transplantation for Acute Myeloid Leukemia: Challenging Its Predictive Value.

Loredana Ruggeri, MD, PhD, Antonella Mancusi, PhD, Marusca Capanni, M.Sc(Biol), Elena Urbani, M.Sc(Biol), Alessandra Carotti, MD, Teresa Aloisi, MD, Martin Stern, MD, Katia Perruccio, MD, PhD, Emanuela Burchielli, MD, PhD, Fabiana Topini, M.Sc(Biol), Erika Bianchi, M.Sc(Biol), Franco Aversa, MD, Massimo F. Martelli, MD, Andrea Velardi, MD

Blood (2006) 108 (11): 437.

https://doi.org/10.1182/blood.V108.11.437.437

Published: 2006

Journal Articles

Hematopoietic Stem Cell Transplantation (HSCT) from Alternative Donors for Acute Leukemia at High-Risk of Relapse. The Haploidentical Option.

Franco Aversa, MD, Antonio Tabilio, MD, Adelmo Terenzi, MD, Stelvio Ballanti, MD, Alessandra Carotti, MD, Franca Falzetti, MD, Andrea Velardi, MD, Teresa Aloisi, MD, Leonardo Flenghi, MD, Jean Pierre Saab, MD, Yair M. Reisner, PhD, Massimo F. Martelli, MD

Blood (2005) 106 (11): 441.

https://doi.org/10.1182/blood.V106.11.441.441

Published: 2005

Journal Articles

Donor Activating Kir Genes and Survival after Haplo-Identical Hematopoietic Transplantation.

Antonella Mancusi, MSc, Loredana Ruggeri, MD PhD, Karina McQueen, PhD, Katia Perruccio, MD, Franco Aversa, MD, Massimo F. Martelli, MD, Peter Parham, MD PhD, Andrea Velardi, MD

Blood (2004) 104 (11): 2219.

https://doi.org/10.1182/blood.V104.11.2219.2219

Published: 2004

Journal Articles

T-Cell Depletion and No Post-Transplant Immune Suppression Provides Better Immune Recovery to Aspergillus Than Conventional T Cell-Replete Hematopoietic Transplants.

Katia Perruccio, MD, Simone Cesaro, MD, Fabiana Topini, MSc, Maria Vittoria Gazzola, MSc, Emanuela Burchielli, MD, Alessandra Barzan, MD, Franco Aversa, MD, Chiara Messina, MD, Massimo F. Martelli, MD, Andrea Velardi, MD

Blood (2004) 104 (11): 2221.

https://doi.org/10.1182/blood.V104.11.2221.2221

Published: 2004

Journal Articles

Prospects for Dendritic Cell Vaccination Against Fungal Infections in Hematopoietic Transplantation.

Katia Perruccio, MD, Silvia Bozza, MD, Claudia Montagnoli, MSc, Silvia Bellocchio, MSc, Franco Aversa, MD, Massimo F. Martelli, MD, Francesco Bistoni, MD, Andrea Velardi, MD, Luigina Romani, MD, PhD

Blood (2004) 104 (11): 2139.

https://doi.org/10.1182/blood.V104.11.2139.2139

Published: 2004

NARROW

Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation

Adoptive Immunotherapy with Regulatory and Conventional T Cells in Haploidentical Transplantation Primes Dendritic Cells to Promote T Cell Alloreactivity in the Bone Marrow and Tolerance in the Periphery

Activation of Regulatory T Cells with IL-2 and TNF-α to Promote Homing to the Gut and to Improve Acute GvHD Prevention

Low-Toxicity/High-Efficacy HLA Haploidentical Transplantation for Elderly/Unfit Patients with Acute Leukemia

Allogeneic Genetically Modified T Cells (HSV-TK) As Adjunctive Treatment in Haploidentical Hematopoietic Stem-Cell Transplantation (haplo-HSCT) of Adult Patients with High-Risk Hematological Malignancies: A Pair-Matched Analysis from the Acute Leukemia Working Party of EBMT

Alternative Donors (Umbilical Cord Blood and Haploidentical Donors) for Allogeneic Stem Cell Transplantation in Relapsed / Refractory Hodgkin Lymphoma: A Retrospective Analysis of the EBMT Lymphoma Working Party and the Spanish Group of Stem Cell Transplantation (GETH)

Myeloablative Versus Reduced Intensity Allogeneic Stem Cell Transplantation in Relapsed Hodgkin’s Lymphoma in Recent Years. a Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Haploidentical Mismatched Allogeneic Versus Autologous Hematopoietic STEM CELL Transplantation in Adult Patients with ACUTE Myeloid Leukemia (AML) in First Complete Remission (CR1): A Pair-Matched Analysis From the Acute Leukemia Working Party of EBMT.

Reduction in Incidence of Severe Infections by Transplantation of High Doses of Haploidentical T Cells Selectively Depleted of Alloreactive Units

Permissive HLA-DPB1 Mismatching Compared to a Non-Permissive Mismatching Significantly Improves Overall Survival Following Allogeneic Transplantation In Patients with Both 10/10 and 9/10 Matched Unrelated Donors

Adoptive Therapy with T-Cell Precursors for Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation.

Adoptive Immunotherapy after Haploidentical Stem Cell Transplantation with T Cells Allodepleted by Photodynamic Purging

Phase I-II Trial of Adoptive Immunotherapy with Haploidentical KIR Ligand-Mismatched Natural Killer Cells in High Risk Acute Myeloblastic Leukemia Patients.

Anti-KIR (1-7F9): A Fully Human Monoclonal Antibody (mAb) That Blocks KIR2DL1, −2 and −3, Promoting Natural Killer (NK) Cell-Mediated Lysis of Tumor Cells In Vitro and In Vivo.

Alloreactive Natural Killer Cells Rebuild Adaptive Immunity to Infections after Haploidentical Hematopoietic Transplantation.

Donor Natural Killer Cell Allorecognition of Missing Self in Haploidentical Hematopoietic Transplantation for Acute Myeloid Leukemia: Challenging Its Predictive Value.

Hematopoietic Stem Cell Transplantation (HSCT) from Alternative Donors for Acute Leukemia at High-Risk of Relapse. The Haploidentical Option.

Donor Activating Kir Genes and Survival after Haplo-Identical Hematopoietic Transplantation.

T-Cell Depletion and No Post-Transplant Immune Suppression Provides Better Immune Recovery to Aspergillus Than Conventional T Cell-Replete Hematopoietic Transplants.

Prospects for Dendritic Cell Vaccination Against Fungal Infections in Hematopoietic Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only